By Fola Akinnibi ( October 5, 2016, 5:32 PM EDT) -- Eli Lilly and Co.'s animal health subsidiary agreed Wednesday to purchase Boehringer Ingelheim Vetmedica Inc.'s U.S. feline, canine and rabies vaccine portfolio in an $885 million deal that is part of its parent company's bid to gain antitrust approval for a deal that was announced in December....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.